First published in The Journal of Clinical Pharmacology on 2015 Apr.J Clin Pharmacol. 2015 Apr;55(4):384-91. doi: 10.1002/jcph.418. Epub 2014 Dec...
Read Article
This open-label, nonrandomized, single-dose, phase 1 study evaluated the pharmacokinetics and safety of murepavadin, a novel peptide antibiotic for the treatment of serious Pseudomonas aeruginosa infections.